Role of Diabetes Mellitus and Hypertension in the Progression of Chronic Kidney Disease a Systematic Review
DOI:
https://doi.org/10.56570/jimgs.v1i2.35Keywords:
Chronic kidney disease, diabetes, hypertension, glomerular filtration rate, blood pressure, mortalityAbstract
Chronic kidney disease(CKD) is defined as an EGFR(Estimated glomerular filtration rate) < 60 ml/min/1.73 m2 or an EGFR ≥60 ml/min/1.73 m2 together with albuminuria (≥30 mg/g).It causes significant mortality and morbidity. It is a silent killer. The prevalence of CKD has been increasing worldwide. There are many established risk factors for chronic kidney disease, the two most important ones being hypertension and diabetes mellitus(DM). In this systematic review, we aim to know the roles of hypertension (HTN) and diabetes in the progression of chronic kidney disease. We did a detailed search on PubMed and found 1216 articles screened, and finally, 20 articles were chosen for study. As we analyzed, we observed that most studies showed that diabetes and hypertension have a positive association with the progression of CKD, even though the exact mechanism or link has not been explained in the studies we reviewed.
References
Ahmed MA, Ferede YM, Takele WW. Incidence and predictors of chronic kidney disease in type-II diabetes mellitus patients attending at the Amhara region referral hospitals, Ethiopia: A follow-up study. PLoS One. 2022;17(1):e0263138. doi:10.1371/journal.pone.0263138
Ali I, Chinnadurai R, Ibrahim ST, Green D, Kalra PA. Predictive factors of rapid linear renal progression and mortality in patients with chronic kidney disease. BMC Nephrol. Aug 14 2020;21(1):345. doi:10.1186/s12882-020-01982-8
Bramlage P, Lanzinger S, Hess E, et al. Renal function deterioration in adult patients with type-2 diabetes. BMC Nephrol. Jul 29, 2020;21(1):312. doi:10.1186/s12882-020-01952-0
Carpio EM, Ashworth M, Asgari E, et al. Hypertension and cardiovascular risk factor management in a multi-ethnic cohort of adults with CKD: a cross-sectional study in general practice. J Nephrol. Apr 2022;35(3):901-910. doi:10.1007/s40620-021-01149-0
Chang TI, Lim H, Park CH, et al. Associations of Systolic Blood Pressure With Incident CKD G3-G5: A Cohort Study of South Korean Adults doi.org/10.1053/j.ajkd.2020.01.013
Hao Y, Li X, Zhu Y, et al. Effect of age and isolated systolic or diastolic hypertension on target organ damage in non-dialysis patients with chronic kidney disease. Aging (Albany NY). Feb 22 2021;13(4):6144-6155. doi:10.18632/aging.202609
Jitraknatee J, Ruengorn C, Nochaiwong S. Prevalence and Risk Factors of Chronic Kidney Disease among Type 2 Diabetes Patients: A Cross-Sectional Study in Primary Care Practice. Sci Rep. Apr 10, 2020;10(1):6205. doi:10.1038/s41598-020-63443-4
Joo YS, Lee C, Kim HW, et al. Association of Longitudinal Trajectories of Systolic BP with Risk of Incident CKD: Results from the Korean Genome and Epidemiology Study. J Am Soc Nephrol. Sep 2020;31(9):2133-2144. doi:10.1681/ASN.2020010084
Lee JY, Park JT, Joo YS, et al. Association of Blood Pressure With the Progression of CKD: Findings From KNOW-CKD Study doi.org/10.1053/j.ajkd.2020.12.013
Liu C, Tian J, Jose MD, He Y, Dwyer T, Venn AJ. Associations of a healthy lifestyle score from childhood to adulthood with subclinical kidney damage in midlife: a population-based cohort study. BMC Nephrol. Jan 3 2022;23(1):2. doi:10.1186/s12882-021-02627-0
Neves JS, Correa S, Baeta Baptista R, Bigotte Vieira M, Waikar SS, Mc Causland FR. Association of Prediabetes With CKD Progression and Adverse Cardiovascular Outcomes: An Analysis of the CRIC Study. J Clin Endocrinol Metab. Apr 1 2020;105(4)doi:10.1210/clinem/dgaa017
Nichols GA, Deruaz-Luyet A, Brodovicz KG, Kimes TM, Rosales AG, Hauske SJ. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes. BMC Nephrol. May 7 2020;21(1):167. doi:10.1186/s12882-020-01792-y
Nowak KL, Chonchol M, Jovanovich A, et al. Arterial stiffness and kidney disease progression in the systolic blood pressure intervention trial. Clin Nephrol. Jul 2020;94(1):26-35. doi:10.5414/CN109982
Rahman M, Wang X, Bundy JD, et al. Prognostic Significance of Ambulatory BP Monitoring in CKD: A Report from the Chronic Renal Insufficiency Cohort (CRIC) Study. J Am Soc Nephrol. Nov 2020;31(11):2609-2621. doi:10.1681/ASN.2020030236
Sharma M, Parry MA, Jeelani H, Mahanta PJ, Doley PK, Pegu G. Prevalence of Nondiabetic Renal Disease in Patients with Type 2 Diabetes Mellitus with Clinicopathological Correlation: A Study from a Tertiary Care Center of Assam, India, Saudi J Kidney Dis Transpl [serial online] 2020 [cited 2022 Aug 31];31:831-9. Available from: https://www.sjkdt.org/text.asp?2020/31/4/831/292318
Suijk DL, Smits MM, Muskiet MH, et al. Plasma uric acid and renal hemodynamics in type 2 diabetes patients. Nephrology (Carlton). Apr 2020;25(4):290-297. doi:10.1111/nep.13645
Takamatsu K. Renal status in elderly patients with type 2 diabetes. Clin Exp Nephrol. Jan 2020;24(1):53-62. doi:10.1007/s10157-019-01792-9
Wang HY, Meng Q, Yang C, et al. Association between pulse pressure, systolic blood pressure and the risk of a rapid decline of kidney function among the general population without hypertension: results from the China health and retirement longitudinal study (CHARLS). J Transl Med. Dec 20 2021;19(1):512. doi:10.1186/s12967-021-03176-8
Wang Q, Wang Y, Wang J, Zhang L, Zhao MH, Chinese Cohort Study of Chronic Kidney D. White-coat hypertension and incident end-stage renal disease in patients with non-dialysis chronic kidney disease: results from the C-STRIDE Study. J Transl Med. Jun 15 2020;18(1):238. doi:10.1186/s12967-020-02413-w
Wang Q, Wang Y, Wang J, et al. Nocturnal Systolic Hypertension and Adverse Prognosis in Patients with CKD. Clin J Am Soc Nephrol. Mar 8 2021;16(3):356-364. doi:10.2215/CJN.14420920
Page MJ, McKenzie JE, Bossuyt PM, et al.: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:10.1136/bmj.n71
